PhaseV is attending the 2026 CDISC TechniCon on 9 September 2026.
Published
Signal category
Presence & Recognition
Quote
“PhaseV is looking forward to be part of the 2026 CDISC TechniCon!”
— PhaseV team
Company
PhaseV
Adaptive. Causal. Intuitive.
- Industry
- Biotechnology Research
- Location
- Cambridge, US
- Company size
- 75 employees
PhaseV is a Boston-based technology company transforming clinical development with an enterprise-ready AI/ML platform that accelerates decisions, de-risks trials, and drives portfolio efficiency. Its Trial Optimizer designs smarter studies, reducing costs by up to 50%, lowering enrollment needs by 40%, shortening timelines by 40%, and boosting probability of success by 30%+. The ClinOps Optimizer enhances site selection by integrating patient-level insights with real-time dashboards to track performance. The Lifecycle Management module combines causal evidence, development complexity, and market value to inform portfolio decisions. Together, these solutions enable sponsors and CROs to optimize every stage of development.